SEC Form 4 · accession 0001209191-18-020885
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Ambrogi
Officer — Chief Operating Officer
Period of report
Mar 19, 2018
Accepted (ET)
Mar 20, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 19, 2018 | M | 49,728 | $0.23 | A | 146,558 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $0.23 | Mar 19, 2018 | M | 49,728 | A | — | Jan 10, 2019 | Ordinary Shares | 49,728 | 0 | D |
Explanation of responses
- F1Fully vested and currently exercisable as of the date hereof.